Walgreens to buy remaining 30% stake in Shields Health for $1.37B
Justin Sullivan/Getty Images News


Walgreens Boots Alliance (NASDAQ:WBA) said it will acquire the remaining 30% stake of Shields Health Solutions for about $1.37B.

Last year in September, Walgreens made a majority investment in Shields with about $970M of investment, increasing the pharmacy retailerâs stake in the company to nearly 71%.

The company expects to close the transaction by the end of this year.
The specialty pharmacies firm Shields has served more than 1 million patients, with nearly 80 health system partners representing about 1,000 hospitals nationwide.
John Lucey, co-founder and current president of Shields, will lead the organization as CEO of Shields, and current Shields CEO Lee Cooper will take on a new executive role within WBA, the company said.